DXCM DEXCOM INC.

Dexcom Announces Upcoming Conference Presentation

(NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, and Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4th.

The live presentation is scheduled to begin at approximately 11:00 AM EST and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information on Dexcom, visit .

Category: IR

EN
28/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEXCOM INC.

 PRESS RELEASE

Dexcom and ŌURA Announce Strategic Partnership

SAN DIEGO & SAN FRANCISCO--(BUSINESS WIRE)-- (NASDAQ:DXCM), the global leader in glucose biosensing, and , maker of the world’s leading smart ring, announced today a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from Oura Ring. Combining Dexcom glucose data with the biometrics collected by Oura Ring will provide users of both products with a more complete picture of overall health. Dexcom is also making a $75 million strategic investment in ŌURA Serie...

 PRESS RELEASE

Dexcom Helps People With Diabetes Take the First Step to Discover What...

SAN DIEGO--(BUSINESS WIRE)-- This World Diabetes Day, (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first step to discover what they’re made of. This comes as global data1 shows nearly 70% of people with diabetes say they didn’t know where to begin their health journey when they were first diagnosed, and nearly half said diabetes has limited their ability to pursue a passion or interest. This press release features multimedia. View the full release here: Dexcom is teaming up with its thousands of global brand advo...

 PRESS RELEASE

Dexcom Reports Third Quarter 2024 Financial Results

SAN DIEGO--(BUSINESS WIRE)-- (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights: Revenue grew 2% year-over-year to $994.2 million on a reported basis and 3% year-over-year on an organic1 basis. U.S. revenue declined 2% and international revenue grew 12% on a reported basis and 16% on an organic1 basis, all on a year-over-year basis. GAAP operating income of $152.0 million or 15.3% of revenue, a decrease of 580 basis points compared to the third quarter of 2023. Non-GAAP operating income* of $21...

 PRESS RELEASE

Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness W...

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in partnership with the nonprofit , are teaming up with author, producer and actress Retta to establish National Glucose Awareness Week from Sept. 23-29, 2024. will help close the glucose knowledge gap and encourage people to take action to own their glucose health. This press release features multimedia. View the full release here: Actress Retta teams up with Dexcom and Beyond Type 2 to establish National Glucose Awareness Week. (Photo: Business Wire) Understand...

 PRESS RELEASE

Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes t...

SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of , the company’s groundbreaking NIL (name, image, likeness) program exclusively for college athletes with diabetes. This press release features multimedia. View the full release here: The Dexcom U 2024 roster consists of 20 athletes who all use Dexcom CGM to monitor their glucose levels and manage their diabetes (Graphic: Dexcom) Heralded by Ad Age as a after its inaugural season in 2022, the 2024 Dexcom U s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch